FDA’s Avian Flu Rapid Response Team Will Make Antiviral Reviews A Priority
This article was originally published in The Pink Sheet Daily
Executive Summary
The newly created team will look at vaccine development, but its main focus will be addressing roadblocks to manufacturing treatments such as Roche’s Tamiflu.